HomeInsights52 Week Low Stocks

Astrazeneca Pharma India Ltd 52 Week Low

Astrazeneca Pharma India Ltd 52 Week Low

stocks purchased

₹ 0.4 Cr

Volume transacted

stocks purchased

0.6 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Astrazeneca Pharma India Ltd

NSE: ASTRAZEN

YEARLOW

4050.15

Last updated: 18 Sep 24

Key Highlights

  • The 52 Week Low of Astrazeneca Pharma India Ltd is ₹ 4050 as of 18 Sep 24.

Company Fundamentals for Astrazeneca Pharma India Ltd

No data available

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Astrazeneca Pharma India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 20246703
17 Sep 20246669.65
16 Sep 20246757
13 Sep 20246791
12 Sep 20246836.65
11 Sep 20246906.25
10 Sep 20246887.15
09 Sep 20246768.55
06 Sep 20246898.3
05 Sep 20246896.9

Asset Value vs Market Value of Astrazeneca Pharma India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Historical Net Profit of Astrazeneca Pharma India Ltd

No data available

* All values are in crore

Astrazeneca Pharma India Ltd News Hub

News

AstraZeneca slumps on recording dismal Q1 performance

Revenue from operations jumped 31.15% year on year (YoY) to Rs 387.52 crore in the quarter...

Read more

08 Aug 202416:08

News

Astrazeneca Pharma India to hold board meeting

Astrazeneca Pharma India will hold a meeting of the Board of Directors of the Company on 8...

Read more

24 Jul 202416:06

News

Astrazeneca Pharma India schedules AGM

Astrazeneca Pharma India announced that the Annual General Meeting (AGM) of the company wi...

Read more

18 Jul 202410:03

News

Volumes soar at Astrazeneca Pharma India Ltd counter

Inox Wind Ltd, Restaurant Brands Asia Ltd, Rites Ltd, Lloyds Metals & Energy Ltd are among...

Read more

04 Jul 202414:30

News

Board of Astrazeneca Pharma India recommends final dividend

Astrazeneca Pharma India announced that the Board of Directors of the Company at its meeti...

Read more

28 May 202409:52

News

AstraZeneca Pharma Q4 PAT soars 129% YoY to Rs 39 cr

Revenue from operations jumped 34.6% to Rs 383.2 crore during the quarter as compared with...

Read more

28 May 202411:45

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week Low of Astrazeneca Pharma India Ltd

Why is it important to track the 52-week low of Astrazeneca Pharma India Ltd stocks?

Investors should monitor the 52-week low of Astrazeneca Pharma India Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Astrazeneca Pharma India Ltd stocks hitting a 52-week low?

Factors leading to Astrazeneca Pharma India Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Astrazeneca Pharma India Ltd stocks when they hit a 52-week low?

Buying Astrazeneca Pharma India Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Astrazeneca Pharma India Ltd stocks?

Investors should monitor the 52-week low of Astrazeneca Pharma India Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Astrazeneca Pharma India Ltd stock at their 52-week low?

An investor can analyze the reasons for the Astrazeneca Pharma India Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Astrazeneca Pharma India Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Astrazeneca Pharma India Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Astrazeneca Pharma India Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*